Aldeyra Therapeutics (ALDX) Misses Q3 EPS by 5c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.35), $0.05 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge